Research ArticleTheranostics
Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment
Luis David Jiménez-Franco, Gerhard Glatting, Vikas Prasad, Wolfgang A. Weber, Ambros J. Beer and Peter Kletting
Journal of Nuclear Medicine January 2021, 62 (1) 92-98; DOI: https://doi.org/10.2967/jnumed.120.245068
Luis David Jiménez-Franco
1ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft mbH, Dresden, Germany
Gerhard Glatting
2Department of Nuclear Medicine, Ulm University, Ulm, Germany
3Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, Ulm, Germany; and
Vikas Prasad
2Department of Nuclear Medicine, Ulm University, Ulm, Germany
Wolfgang A. Weber
4Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
Ambros J. Beer
2Department of Nuclear Medicine, Ulm University, Ulm, Germany
Peter Kletting
2Department of Nuclear Medicine, Ulm University, Ulm, Germany
3Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, Ulm, Germany; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 1
January 1, 2021
Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment
Luis David Jiménez-Franco, Gerhard Glatting, Vikas Prasad, Wolfgang A. Weber, Ambros J. Beer, Peter Kletting
Journal of Nuclear Medicine Jan 2021, 62 (1) 92-98; DOI: 10.2967/jnumed.120.245068
Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment
Luis David Jiménez-Franco, Gerhard Glatting, Vikas Prasad, Wolfgang A. Weber, Ambros J. Beer, Peter Kletting
Journal of Nuclear Medicine Jan 2021, 62 (1) 92-98; DOI: 10.2967/jnumed.120.245068
Jump to section
Related Articles
Cited By...
- Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
- Mathematic Modeling of Tumor Growth During [177Lu]Lu-PSMA Therapy: Insights into Treatment Optimization
- Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine